Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I safety and immunogenicity trial of a combination vaccine (NefTat and gp120w61d) formulated with AS02A (GlaxoSmithKline Biologicals) given intramuscularly in HIV-1-uninfected adult participants
Description
HVTN 041 is a Phase I clinical trial to evaluate the safety and immunogenicity of NefTat and gp120w61d formulated with AS02A.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.